Other languages ExpreS2ion Biotech Holding AB

Equities

EXPRS2

SE0008348262

Market Closed - Nasdaq Stockholm Other stock markets 09:30:00 28/06/2024 pm IST			5-day change	1st Jan Change
1.16 ^SEK	-0.17%		+7.41%	-45.02%

16/05	ExpreS2ion Biotech Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
16/04	ExpreS2ion Announces Completion of GLP Safety Study for ES2B-C001 (HER2-VLP) Breast Cancer Vaccine Candidate	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ExpreS2ion Biotech Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024	16/05
ExpreS2ion Announces Completion of GLP Safety Study for ES2B-C001 (HER2-VLP) Breast Cancer Vaccine Candidate	16/04
ExpreS2ion Biotech JV Secures EUR10 Million Following Bavarian Nordic's Completion of COVID-19 Vaccine Trial	21/02
ExpreS2ion Biotech Unit Secures EUR8 Million Grant for Virus Vaccine Project; Shares Soar	01/12
ExpreS2ion Biotech Holding AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	16/11
ExpreS2ion Biotech Holding AB Announces Changes to Leadership Team	27/23/27
Expres2ion Biotech Affiliate to Assess Strategic Options for Breast Cancer Project	17/23/17
ExpreS2ion Biotech Holding AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	17/23/17
ExpreS2ion Biotech Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2023	16/23/16
ExpreS2ion Biotech Holding AB Auditor Raises 'Going Concern' Doubt	02/23/02
ExpreS2ion Biotech to Issue New Units to Guarantors Under Rights Issue	21/23/21
ExpreS2ion Biotech Holding AB Reports Earnings Results for the Full Year Ended December 31, 2022	09/23/09
ExpreS2ion Biotech Holding AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	09/23/09
ExpreS2ion Biotech Holding AB Appoints Dr. Farshad Guirakhoo as Chief Scientific Officer, Effective January 16, 2023	03/23/03
ExpreS2ion and Evaxion Biotech A/S Initiates Research Collaboration on a Novel Cytomegalovirus Vaccine Candidate	06/22/06
ExpreS2ion Biotech Holding AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	17/22/17
Expres2ion Biotech Holding AB Announces Durable Antibody Response Reported for the Abncov2 Covid-19 Vaccine Six Months After Vaccination in the Phase Ii Clinical Trial	17/22/17
ExpreS2ion Biotech Holding AB Announces Resignation of Allan Rosetzsky from the Board of Directors	06/22/06
ExpreS2ion Biotech Holding AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	18/22/18
ExpreS2ion Biotech Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2022	31/22/31

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages ExpreS2ion Biotech Holding AB

Equities

EXPRS2

SE0008348262

Other languages

Filters